ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer and Shionogi as shareholders, announced new data from the phase I CLARITY open-label crossover study, highlighting significant differences in injection site reaction (ISR) acceptability and overall tolerability between…
Zoetis Inc. today announced that Health Canada has approved Lenivia® (izenivetmab injection) for the treatment of pain associated with osteoarthritis (OA) in dogs. Lenivia represents a novel monoclonal antibody therapy, developed over a decade of rigorous scientific research, designed to…
MindWalk Holdings Corp.™, a Bio-Native AI company transforming life sciences data intelligence, today announced the appointment of industry veteran Thomas W. Lynch, Ph.D., as Chief Business Officer (CBO), effective October 20, 2025. This strategic hire is aimed at accelerating the…
Augurex Life Sciences Corp., a leading innovator in autoimmune-based diagnostics, today announced a strategic partnership with MitogenDx, a Canadian specialty laboratory focused on autoimmune and rheumatology testing. Under the agreement, MitogenDx will offer Augurex’s JOINTstat® blood test, significantly expanding access…
Next Health, recognized globally as a leader in health optimization and longevity medicine, has officially launched its Scientific Advisory Council—a distinguished assembly of physicians, scientists, and innovators committed to shaping the future of proactive healthcare. Led by Founder and CEO…
Frontier Scientific Solutions (Frontier) and Air Transport Services Group, Inc. (ATSG) have announced a landmark strategic partnership aimed at redefining the global delivery of temperature-sensitive pharmaceuticals. The collaboration introduces a purpose-built air corridor exclusively designed for life sciences, ensuring uninterrupted…
Tubulis, a leading biotechnology company focused on developing next-generation antibody-drug conjugates (ADCs), today announced the successful closing of a €308 million (USD 361 million) Series C financing round — one of the largest private financings in the European biotech sector…
Orum Therapeutics, a public biotechnology company pioneering the development of degrader–antibody conjugates (DACs), has announced the appointment of Dorin Toader, Ph.D., as Head of Platform Technology. With over 27 years of experience in drug discovery and more than 15 years…
insitro, a leading machine learning–driven drug discovery and development company, has announced the next phase of its ongoing collaboration with Bristol Myers Squibb (NYSE: BMY) to develop novel therapeutics for amyotrophic lateral sclerosis (ALS). The collaboration extension deepens the partnership’s…
Lasso, a next-generation food technology company, today officially launched with the unveiling of its proprietary Lasso SpinTech, a physics-based system designed to revolutionize how modern packaged foods are made. The breakthrough technology blends protein and fiber in a completely new…